As of Sep 26
| -0.0091 / -1.54%|
The 3 analysts offering 12-month price forecasts for Biocept Inc have a median target of 1.20, with a high estimate of 2.50 and a low estimate of 0.80. The median estimate represents a +105.80% increase from the last price of 0.58.
The current consensus among 3 polled investment analysts is to Buy stock in Biocept Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.